• Our Offering
    • small molecules

      • Preclinical Services
      • IND/Clinical Supply
      • Drug Substance
      • API
      • Advanced Intermediate
      • Highly Potent API
      • ADC Payload
      • Solid Form Services
      • Drug Product
      • Particle Engineering
      • Bioavailability Enhancement
      • Oral Solid
      • Inhalation
      • Parenteral
    • biologics

      • Preclinical Offering
      • Expression Technologies
      • Discovery Services
      • Drug Substance
      • Mammalian
      • Microbial
      • ADCs / Bioconjugates
      • Ibex® Solutions
      • Drug Product
      • Parenteral
    • cell & gene

      • Allogeneic Cell Therapy
      • iPSC Manufacturing
      • Exosomes
      • Cell Based Immunotherapies
      • Autologous Cell Therapy
      • Cell Based Immunotherapies
      • Viral Vectors
      • Services
      • Process Development
      • cGMP Manufacturing
      • Regulatory Support
      • Tissue Acquisition
      • Products
      • Cocoon® Platform
    • bioscience

      • Primary & Stem Cells
      • Bioprocessing Media
      • CellBio Services
      • Culture Media & Reagents
      • ADME & Toxicology
      • Transfection
      • Cell Assays & Analysis
      • Electrophoresis
      • Informatics – Paperless Solutions
      • QC & Endotoxin Detection
      • Automated Sterile Sampling
    • capsules

      • Immediate Release
      • Modified Release
      • Vegetarian
      • Inhalation
      • Over the Counter (OTC)
      • IND / Clinical Supply
      • Equipment
  • Resources
      • technologies & products

        We develop proprietary technology and licensing partnerships to ensure you have access to best-in-class solutions that add value to your own science.

      • regulatory support

        In close collaboration with you, Lonza Regulatory Affairs provide a CMC dossier suitable to the stage of clinical development of your product manufactured by Lonza.

      • technical support

        The collective expertise of our multi-disciplinary team in protein expression and production processes can help you get the most from our industry-leading technologies.

      • knowledge center

        Gather additional industry and technical information from our repository of resources and educational content.

  • About Us
      • about us

        Delivering the medicines of tomorrow today

      • careers

        Find opportunities

      • news

        View press releases

      • locations

        View our locations

      • events

        the next conversation...

      • meet our experts

  • Contact Us
Our Offering
small molecules
  • Preclinical Services
  • IND/Clinical Supply
  • Drug Substance
  • API
  • Advanced Intermediate
  • Highly Potent API
  • ADC Payload
  • Solid Form Services
  • Drug Product
  • Particle Engineering
  • Bioavailability Enhancement
  • Oral Solid
  • Inhalation
  • Parenteral
biologics
  • Preclinical Offering
  • Expression Technologies
  • Discovery Services
  • Drug Substance
  • Mammalian
  • Microbial
  • ADCs / Bioconjugates
  • Ibex® Solutions
  • Drug Product
  • Parenteral
cell & gene
  • Allogeneic Cell Therapy
  • iPSC Manufacturing
  • Exosomes
  • Cell Based Immunotherapies
  • Autologous Cell Therapy
  • Cell Based Immunotherapies
  • Viral Vectors
  • Services
  • Process Development
  • cGMP Manufacturing
  • Regulatory Support
  • Tissue Acquisition
  • Products
  • Cocoon® Platform
bioscience
  • Primary & Stem Cells
  • Bioprocessing Media
  • CellBio Services
  • Culture Media & Reagents
  • ADME & Toxicology
  • Transfection
  • Cell Assays & Analysis
  • Electrophoresis
  • Informatics – Paperless Solutions
  • QC & Endotoxin Detection
  • Automated Sterile Sampling
capsules
  • Immediate Release
  • Modified Release
  • Vegetarian
  • Inhalation
  • Over the Counter (OTC)
  • IND / Clinical Supply
  • Equipment
Resources
technologies & products
regulatory support
technical support
knowledge center
About Us
about us
careers
news
locations
events
meet our experts
Contact Us

technologies & products

We develop proprietary technology and licensing partnerships to ensure you have access to best-in-class solutions that add value to your own science.

Filter by Page Properties
Discovery Services (17) Oral Drug Products and Intermediates (15) Immunogenicity Assessment (9) BA Enhancement (8) Cell and Gene Therapies (6) Formulation and Product Development (6) Vaccine Design and Development (6) in vitro screening for vaccines (6) Allogeneic Cell Therapy (5) Commercial Manufacture of Drug Products & Intermediates (5) Modified and Targeted Delivery (5) Small Molecules and Intermediates (5) in vitro screening for biotherapeutics (5) Cell Line Development (4) Mammalian (4) API Commercial Production Services (3) Autologous Cell Therapy (3) Clinical Trial Manufacture (3) Drug Products Intermediate Development (3) HPAPI Product Handling (3) Particle Engineering Services (3) Product Design and Preformulation Development (3) Protein Expression (3) Bioconjugates (2) Drug Substance Manufacture (2) Low Dose and High Potent Applications (2) Pediatric Product Development (2) Process Definition and Sample Preparation (2) Process Development and Optimization (2) API Research & Development Services (1) Antibody Humanization and Deimmunization (1) Capsule Delivery Solutions (1) Drug Product Manufacture (1) Formulation Development (1) Microbial (1) Protein Engineering (1) SimpliFIH Solutions (1) Targeting Agent and Carrier Protein (1)
Showing 43‐47 of 47
results per page
technology
Light Path™ Protein Production
Light Path™ Protein Production – gene to product offerings supporting preclinical and phase I studies for microbial or mammalian proteins.
technology
Multiparticulate Technologies
We utilize four multiparticulate technologies for meeting target product profiles, with the choice being dependent upon API parameters, formulation requirements and commercial objectives.
technology
Nucleofector™ Products
Nucleofector™ Products for efficient non-viral modification of primary cells, enabling generation of iPSC or CAR-T cells, or CRISPR-mediated engineering.
technology
Osmotic Tablet Technologies
We use two osmotic tablet technologies that are highly flexible, can be utilized with both crystalline and amorphous drug substances, and utilize osmotic/hydrostatic pressure to provide consistent drug release without food effect.
technology
Technology Selection
We have developed models, reference tools and methodologies to accelerate technology selection for BCS II compounds.
< 1 2 3
About Us
  • Careers
  • Events
  • Locations
  • News
Resources
  • Knowledge Center
  • Technologies and Products
  • Technical Support
  • Regulatory Support
Terms
  • Legal Disclaimer
  • Privacy Policy
  • Sitemap
www.lonza.com
© 2021 Lonza. All Rights Reserved.
By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy and Cookie policies.